DTC, GPOs on FTC workshop agenda
Executive Summary
The Federal Trade Commission will consider the influence of DTC advertising on cost and utilization of pharmaceuticals among other issues during upcoming 1healthcare workshop Sept. 9-10. FTC will also consider the effectiveness of the proposed code of conduct for group purchasing organizations (2"The Pink Sheet" Aug. 15, p. 16)...
You may also be interested in...
GPOs Propose Jan. 1 Code-Of-Conduct Compliance Certification Launch
The Health Industry Group Purchasing Association is requesting one year to get member companies into compliance with a 1GPO code of conduct delivered to the Senate Judiciary/Antitrust Subcommittee July 29
More Heartmate Troubles For Abbott. Latest Recall Includes 14 Deaths
Abbott initiated a recall in February of thousands of Heartmate devices due to a system obstruction that can result in serious health outcomes, including death. The FDA has now designated the recall as class I.
‘Unbalanced’ EU HTA Timelines Exacerbated By Rare Disease & Cancer Drugs
As it stands, drugmakers will have just 90 days to prepare their dossiers for EU-wide joint clinical assessments under the new Health Technology Assessment Regulation. Market access experts from EFPIA tell the Pink Sheet that this short deadline could delay patient access to complex medicines, such as innovative cancer drugs.